FILING ANALYSIS · THURSDAY, NOVEMBER 12
ROCKWELL MEDICAL, INC. RMTI — 8-K: Results of Operations and Financial Condition
positive
The company reported a 20% increase in net sales for the third quarter 2026, driven by strong customer adoption and market validation of its products, and announced a projected annual revenue of $400-450 million following its combination with Vantive's global hemodialysis business.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →